Hepatitis C virus seroprevalence among haemodialysis patients, sickle cell patients and blood donors at a tertiary hospital in Yaounde, Cameroon

Ndomgue, Therese; Kengne, Michel; Njukeng, Patrick Achiangia; Ndze, Valentine Ngum; Anong, Damien N.; Masebe, Tracy; Tamoufe, Ubald; Bongajum, Anastasia Yenban; Goon, Daniel Ter; Nwobegahay, Julius M.

doi:10.4102/sajid.v33i1.26

Cited by 1 publication

(2 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, our results from the general SSA search also showed higher HCV prevalence in blood donors in Western Africa and lower prevalence in Southern Africa. There were reports as high as 14.6% 11.7%, 5.8%, 5.6% in Ghana, 8.6%, 6.9%, 6.3% in Burkina Faso and 12.5% in Cameroon 45–52 . In Southern Africa, the highest HCV prevalence was 3.8% in DRC 26 .…”

Section: Discussionmentioning

confidence: 97%

See 1 more Smart Citation

Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa

Puerto‐Meredith,

Singogo,

Chagomerana

et al. 2023

Transfusion Medicine

View full text Add to dashboard Cite

Blood and blood products are listed as one of the essential medicines by the World Health Organization (WHO). In addition to inadequate supply, most sub‐Saharan Africa (SSA) nations fail to meet their blood needs because many donated blood units are discarded because they are contaminated with transfusion‐transmitted infections (TTIs). We sought to estimate the prevalence of TTIs, identify the risk factors for TTIs among blood donors, and identify the efforts and interventions that have been made to improve blood safety in Southern African nations, particularly the nations of the South African Development Community (SADC). We investigated the prevalence and risk factors for TTIs, blood safety interventions, and blood quality improvement in the SADC region from major PubMed/MEDLINE, Cochrane Library, and HINARI databases from 1 January 2011 to 31 April 2021. All investigations followed the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA). In meta‐analysis, we estimated the pooled TTIs prevalence and summarised the same using forest plots. A total of 180 articles published from the SSA region were identified covering our three targeted themes: TTI prevalence, risk factors for TTIs, and blood safety improvements. Of these 180 articles, only 27 (15%) focused on the SADC region. The overall pooled TTI prevalence estimate was 2.0% (95% CI: 1.0–3.0) and hepatitis B was the most prevalent TTI in the region (prevalence = 3.0; 95% CI: 2.0–5.0). The prevalence of HIV, HCV, and syphilis was 2.0% (95% CI: 1.0–4.0), 1.0% (95% CI: 0.0–2.0), and 2.0% (95% CI: 0.0–8.0), respectively. In general, replacement donors and first‐time donors were more likely to be infected with TTIs than repeat donors. Twelve articles explored blood safety research in the region; however, they vary greatly highlighting the need for consistent and more comprehensive research. Few publications were identified that were from the SADC region, indicating lack of research or resources towards improving both quantity and quality of blood donation. TTI prevalence remains one of the highest in the world and blood safety recommendations vary across the region. More effort should be directed towards developing a cohesive regional blood transfusion policy and effective blood monitoring and evaluation strategies.

show abstract

Section: Discussionmentioning

confidence: 97%

“…There were reports as high as 14.6% 11.7%, 5.8%, 5.6% in Ghana, 8.6%, 6.9%, 6.3% in Burkina Faso and 12.5% in Cameroon. [45][46][47][48][49][50][51][52] In Southern Africa, the highest HCV prevalence was 3.8% in DRC. 26 This aligns with findings from the WHO; they report HCV prevalence to be 1.5%…”

Section: Infectious Disease Modellingmentioning

confidence: 99%